Oncology

@onc_ce on Twitter

Disclosures

Faculty                                  Relationship Identified With:
Harold BursteinNothing to disclose
Dr. Aakash DesaiNothing to disclose
Beth Faiman PhD, MSN, SPRN-BC, AOCN, FAANConsultant: Jannssen, Celgene/BMS, Sanofi Genzyme, Karyopharm
Erika Hamilton, MD
RESEARCH FUNDING – ALL PAYMENTS TO INSTITUTION: Abbvie, Acerta Pharma, ADC Therapeutics, AKESOBIO, Australia, Amgen, Aravive, ArQule, Arvinas, AstraZeneca, AtlasMedx, Black Diamond, Boehringer, Ingelheim, Clovis, Compugen, Curis, CytomX, Daiichi Sankyo, Dana Farber Cancer Inst, Deciphera, eFFECTOR Therapeutics, Ellipses Pharma, EMD Serono, Fochon, FujiFilm, G1, Therapeutics, H3 Biomedicin, Harpoon, Hutchinson MediPharma, Immunogen, Immunomedics, Incyte, InvestisBio, Jacobio, Karyopharm, Leap Therapeutics, Lilly, Lycera, Mabspace, Biosciences, Macrogenics, MedImmune, Merck, Mersana, Merus, Millennium, Molecular, Templates, Myraid Genetic Laboratories, Novartis, Nucana, Olema, OncoMed, Onconova, Therapeutics, ORIC Pharmaceuticals, Orinove, Pfizer, PharmaMar, Pieris Pharmaceuticals , Pionyr Immunotherapeutics, Plexxikon, Radius Health, Regeneron, Repertoire Immune Medicine, Rgenix, Roche/Genentech, Seattle Genetics, Sermonix Pharmaceuticals, Shattuck, Labs, Silverback, StemCentRx, Sutro, Syndax, Syros, Taiho, TapImmune, Tesaro, Treadwell Therapeutics, Verastem, Vincerx Pharma, Zenith Epigenetics, Zymeworks
CONSULTING/ADVISORY ROLE – ALL PAYMENTS TO INSTITUTION: Arcus, Arvinas, AstraZeneca, Black Diamond, Boehringer Ingelheim, CytomX, Daiichi Sankyo, Dantari, Deciphera Pharmaceuticals, Eisai, H3 Biomedicine, iTeos, Janssen, Lilly, Loxo, Merck, Mersana, Novartis, Pfizer, Puma Biotechnology, Relay Therapeutics, Roche/Genentech, Seattle Genetics, Silverback Therapeutics
Suneel Kamath, MDAdvisor: Exelixis; Consultant: Tempus, Guardant
Dr. Pashtoon Kasi, MD, MSConsultant/Advisory Board: Ipsen (institution), Natera, Foundation Medicine, AstraZeneca, MSD Oncology/Merck, Tempus, Bayer, Lilly, Delcath Systems, Axiom Healthcare Strategies, IPBA, QED Therepeutics, Boston Healthcare Associates, Servier, Exact Sciences; Research/Grant Funding: BTG/Boston Scientific (institution), Tesera (institution), AAA/Novartis; Travel/Grant Funding to Present IIT at Conference: AstraZeneca
Alok A. KhoranaHonoraria for Consulting: Janssen, Bayer, Sanofi, Pfizer, Anthos, BMS
Dr. C. Ola LandgrenConsultant: Amgen, Janssen, Pfizer, BMS, GSK, Karyopharm, Oncopeptides; Speaker: Sanofi
Dr. Suzanne LentzschEquity Ownership: Caelum Biosciences, Mesoblast, Poseida; Advisory/ Consultant: Caelum Bioscience; Research Grant: Karyopharm, Sanofi; Consultant: Sorrento, Janssen, Celularity, Amgen, Takeda, Gsk, CCO, Oncopeptides
Ruben A. Mesa, MD, FACPConsultant: Blueprint, CTI, Incyte, Novartis, BMS, Abbvie, Geron, PharmaEssentia
Martina Murphy, MDNothing to disclose
Antonio Passaro MD, PhDConsulting or Advisory Role: Roche/Genentech, Bristol Myers Squibb, AstraZeneca, MSD Oncology, Pfizer, Boehringer Ingelheim, Johnson & Johnson/Janssen, Novartis, Lilly
Speakers’ Bureau: AstraZeneca, Johnson & Johnson/Janssen, Boehringer Ingelheim
Dr. Dale ShepardConsultant: Sanofi SA; Research support: Deciphera Pharmaceuticals, Pionyr Immunotherapeutics, Inhibrix, Conjupro Biotherapeutics, Ram Therapeutics, Shanghai Micropeutics, Astellas
Dr. Ann Meredith Garcia TrinidadAdvisory Board: Amgen, Eli Lilly; Speaker: AstraZeneca, Boehringer Ingelheim, MSD, Roche; Writer: Pfizer; Consultant: Sandoz

All relevant financial relationships with ineligible companies for this educational content have been mitigated.